ALZHEIMER DISEASE
Clinical trials for ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Helmet of light: new hope for slowing Alzheimer's?
Disease control TerminatedThis study tested a non-invasive medical device that uses low-level light and magnetic fields, delivered through a helmet and abdominal panel, to see if it could help people with mild-to-moderate Alzheimer's disease. The goal was to see if this light therapy could slow the declin…
Matched conditions: ALZHEIMER DISEASE
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill aims to slow Alzheimer's decline
Disease control TerminatedThis study tested a twice-daily oral medication called varoglutamstat (PQ912) for people with early Alzheimer's disease. The goal was to see if the drug could safely slow the decline in memory and thinking skills. The trial was designed in two parts, starting with about 180 parti…
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Alzheimer's patients test drug for over a year in extended safety study
Disease control TerminatedThis study aimed to check the long-term safety and effects of an experimental drug called XPro1595 in people with Alzheimer's disease. It was an extension for 11 people who had already taken the drug in an earlier trial. Participants received a weekly injection for up to 18 month…
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First human test of new drug for Alzheimer's risk in down syndrome halted early
Disease control TerminatedThis early-stage study aimed to check the safety and how the body processes a new drug called ION269 in adults with Down syndrome who have brain amyloid, a protein linked to Alzheimer's disease. Only one person was enrolled before the study was stopped. The main goal was to see i…
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE1 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major Alzheimer's drug trial halted early
Disease control TerminatedThis study tested whether a drug called simufilam could slow memory and thinking decline in people with mild-to-moderate Alzheimer's disease. About 1,125 participants took either the drug or a placebo pill twice daily for 76 weeks. The trial was terminated early, and researchers …
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE3 • Sponsor: Cassava Sciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Brain-Calcium drug tested for Alzheimer's halted early
Disease control TerminatedThis study tested an oral medication called REM0046127 in people with mild to moderate Alzheimer's disease. It aimed to see if the drug could affect certain brain fluid markers and brain wave patterns, and to check its safety. The trial was terminated early and only enrolled 14 o…
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE2 • Sponsor: reMYND • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Could fighting brain inflammation slow Alzheimer's decline?
Disease control TerminatedThis study aimed to see if anti-inflammatory drugs could help slow cognitive decline in people with early Alzheimer's disease or mild memory problems due to Alzheimer's. It tested one drug in a small group of participants who also showed signs of body-wide inflammation. The trial…
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Brain wave test could spot Alzheimer's earlier
Diagnosis TerminatedThis study tested a special brain scan (EEG) to see if it could help doctors more accurately diagnose Alzheimer's disease and mild cognitive impairment. Researchers compared the brain scan results to standard memory and thinking tests in 148 participants, including healthy adults…
Matched conditions: ALZHEIMER DISEASE
Sponsor: Boston University • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC
-
Swallow sensor trial halted after failing to match gold standard
Diagnosis TerminatedThis study tested a new device called the Dysphagia Detection System (DDS), which is a small sensor worn on the neck. Researchers wanted to see if it could accurately detect unsafe or inefficient swallowing in people with conditions like stroke, Parkinson's, and dementia, compare…
Matched conditions: ALZHEIMER DISEASE
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Mar 16, 2026 15:25 UTC
-
Can better sleep slow memory loss? new study tests Non-Drug approach
Symptom relief TerminatedThis small pilot study tested whether improving sleep patterns could help people with mild memory problems or early Alzheimer's disease. Researchers developed a program combining bright light therapy and behavioral techniques to regulate daytime and nighttime sleep. They aimed to…
Matched conditions: ALZHEIMER DISEASE
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Alzheimer's agitation drug safety study halted
Symptom relief TerminatedThis study aimed to check the long-term safety of AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had completed previous trials of the same medication. The trial was terminated, meaning it ended early before reaching its planned …
Matched conditions: ALZHEIMER DISEASE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Zapping the brain to fight memory loss
Knowledge-focused TerminatedThis study tested whether using magnetic pulses to stimulate specific brain areas could improve memory in older adults with very early signs of Alzheimer's disease. Researchers used brain scans to see how the stimulation changed brain network connections and gave memory tests to …
Matched conditions: ALZHEIMER DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC